As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.

Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain cancers. This issue is particularly pronounced among underrepresented minorities.

There is hope in breast cancer care. While an active diagnosis or genetic testing results can still bring an onslaught of emotions and decisions, a lot more is possible today than once was.

More than 2 million people in the United States are expected to be diagnosed with cancer this year.

People with type 2 diabetes who used glucagon-like peptide analogs such as Ozempic or Mounjaro had a lower risk for multiple types of cancer compared with those who used insulin, according to study results published in JAMA Network Open.

The three biggest pharmacy benefit managers will come before the House Committee on Oversight and Accountability to explain their role in the increasing medication prices in the U.S., according to an announcement on Tuesday by committee Chairman James Comer (R-Ky.).

Hormone-modulating therapy (HMT), which is used to treat breast cancer, may decrease patients’ risk of Alzheimer’s disease and other forms of dementia, according to research published in JAMA Network Open.

Women treated for breast cancer exhibited highly prevalent and distressing sexual health concerns, according to results of the WISH-BREAST study presented at ASCO Annual Meeting.

In a couple of weeks, I will go in for my regular six-month check-up with my oncologist.

In August 2020, the oncological surgeon recommended removing my right breast and replacing it with a plastic reconstruction or implant.